✦ LIBER ✦

Amlodipine plus olmesartan a winning combo in hypertension

✍ Scribed by Cheeseman, M

Book ID: 120842989
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2008
Weight: 180 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200816390-00027

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lercanidipine + enalapril a winning comb

Lercanidipine + enalapril a winning combo in elderly hypertensives

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Olmesartan medoxomil/amlodipine off to a

Olmesartan medoxomil/amlodipine off to a good start in hypertension

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Olmesartan Medoxomil plus Amlodipine Inc

Olmesartan Medoxomil plus Amlodipine Increases Efficacy in Patients with Moderate-to-Severe Hypertension after Monotherapy

✍ Dr Vivencio Barrios, Peter Brommer, Uwe Haag, Alberto Calderón, Carlos Escobar 📂 Article 📅 2009 🏛 Springer International Publishing AG 🌐 English ⚖ 175 KB

Olmesartan/Amlodipine Combination Versus

Olmesartan/Amlodipine Combination Versus Olmesartan or Amlodipine Monotherapies on Blood Pressure and Insulin Resistance in a Sample of Hypertensive Patients

✍ Derosa, Giuseppe; Cicero, Arrigo F.G.; Carbone, Anna; Querci, Fabrizio; Fogari, 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 173 KB

Olmesartan/Amlodipine/Hydrochlorothiazid

Olmesartan/Amlodipine/Hydrochlorothiazide in Obese Participants With Hypertension: A TRINITY Subanalysis

✍ Roth, Eli M.; Oparil, Suzanne; Melino, Michael; Lee, James; Fernandez, Victor; H 📂 Article 📅 2013 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 468 KB

Olmesartan/amlodipine vs olmesartan/hydr

Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study

✍ Martinez-Martin, F J; Rodriguez-Rosas, H; Peiro-Martinez, I; Soriano-Perera, P; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 427 KB

We studied the effects of treatment with olmesartan/amlodipine and olmesartan/hydrochlorothiazide on inflammatory and metabolic parameters (including new-onset diabetes as a secondary endpoint) in non-diabetic hypertensive patients with metabolic syndrome (MetS). A total of 120 patients with MetS an